1. Wang C, Nieschlag E, Swerdloff R et al. Investigation, treatment and monitoring of lateonset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159 (5): 507–14.
2. Cupelian et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006; 91 (3): 843–50.
3. Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391–8.
4. Heufelder A, Gooren L, Bunck M, Saad F. Testosterone Treatment Enhances the Favorable Effects of Exercise and Diet on Inflammation, Metabolism and Coagulation Markers in Hypogonadal Men with the Metabolic Syndrome. Presented at The Endocrine Society Annual Meeting, Toronto, Canada. ENDO 2007. Abstr. OR35-2.
5. Laaksonen et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149 (6): 601–8.
6. Maggio et al. Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc 2006; 54 (12): 1832–8.
7. Makhsida N, Shah J, Yan G et al. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 2005; 174 (3): 827–34.
8. Simanainen U, Brogley M, Gao YR et al. Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol 2011.
9. Ackerman CM, Lowe LP, Lee H et al. Ethnic Variation in Allele Distribution of the Androgen Receptor (AR) (CAG) Repeat. J Androl 2011.